Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.

Antimicrobial Agents and Chemotherapy
R C Goldman, S K Kadam

Abstract

Dimethylation of adenine 2058 in 23S rRNA renders bacteria resistant to macrolides, lincosamides, and streptogramin B (MLS resistance), because the antibiotic binding site on the altered 50S ribosomal subunit is no longer accessible. We now report that certain 6-O-methyl-11,12-cyclic carbamate derivatives of erythromycin are able to bind to dimethylated MLS-resistant 50S ribosomal subunits, thus inhibiting protein synthesis and cell growth. One of these novel structures, an 11-deoxy-11-(carboxyamino)-6-O-methylerythromycin A 11,12-(cyclic ester) derivative, structure 1a, was studied in detail. It inhibited in vitro protein synthesis in extracts prepared from both susceptible and MLS-resistant Bacillus subtilis with 50% inhibitory concentrations of 0.4 and 20 microM, respectively. The derivative bound specifically to a single site on the 50S subunit of MLS-resistant ribosomes prepared from B. subtilis and Staphylococcus aureus, and no binding to 30S subunits was observed. The association rate constant of derivative 1a with sensitive and resistant ribosomes was 100- and 500-fold slower, respectively, than that of the parent compound, erythromycin, with sensitive ribosomes. The dissociation rate constant of 1a from sensitive and r...Continue Reading

References

Jan 1, 1976·Antimicrobial Agents and Chemotherapy·R VinceS Pestka
Jun 20, 1988·Journal of Molecular Biology·M Levitt, M F Perutz
Feb 1, 1987·The Journal of Antibiotics·P F WileyV P Marshall
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·B C LampsonJ T Parisi
Jul 1, 1985·The Journal of Antimicrobial Chemotherapy·J Duval
Oct 1, 1974·Antimicrobial Agents and Chemotherapy·S Pestka
Dec 1, 1974·Journal of Bacteriology·L Legault-Demare, G H Chambliss
Oct 1, 1973·Journal of Bacteriology·P F Sparling, E Blackman
Apr 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·C J Lai, B Weisblum
Sep 14, 1969·Journal of Molecular Biology·J C Mao, M Putterman
Dec 15, 1962·Proceedings of the National Academy of Sciences of the United States of America·R S GARDNERJ F SPEYER

❮ Previous
Next ❯

Citations

Nov 10, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R J KothavadeU R Kothavade
Oct 1, 1996·Diagnostic Microbiology and Infectious Disease·V D ShortridgeS K Tanaka
Nov 24, 1999·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·P ZhongL Katz
Oct 10, 2007·Antimicrobial Agents and Chemotherapy·Jürg DreierMalcolm G P Page
Dec 1, 1995·Antimicrobial Agents and Chemotherapy·T S LucierP C Hu
Apr 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B Vester, S Douthwaite
Jun 19, 2002·Antimicrobial Agents and Chemotherapy·Gervais Clarebout, Roland Leclercq
Jul 5, 2005·Expert Opinion on Investigational Drugs·A Bryskier
Jan 20, 2021·Nature Chemical Biology·Maxim S SvetlovYury S Polikanov
Jun 13, 1998·Antimicrobial Agents and Chemotherapy·A RosatoR Leclercq
Aug 11, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Ping Zhong, Virginia D. Shortridge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.